Gables Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.9K | Hold |
121
| – | – | 0.03% | 201 |
|
|
2025
Q1 | $58.7K | Hold |
121
| – | – | 0.03% | 201 |
|
|
2024
Q4 | $48.7K | Hold |
121
| – | – | 0.02% | 212 |
|
|
2024
Q3 | $56.3K | Hold |
121
| – | – | 0.03% | 204 |
|
|
2024
Q2 | $56.7K | Hold |
121
| – | – | 0.03% | 193 |
|
|
2024
Q1 | $50.6K | Hold |
121
| – | – | 0.03% | 198 |
|
|
2023
Q4 | $49.2K | Hold |
121
| – | – | 0.03% | 194 |
|
|
2023
Q3 | $42.1K | Hold |
121
| – | – | 0.03% | 192 |
|
|
2023
Q2 | $42.6K | Hold |
121
| – | – | 0.03% | 205 |
|
|
2023
Q1 | $38.1K | Hold |
121
| – | – | 0.03% | 212 |
|
|
2022
Q4 | $34.9K | Hold |
121
| – | – | 0.03% | 218 |
|
|
2022
Q3 | $35K | Hold |
121
| – | – | 0.03% | 213 |
|
|
2022
Q2 | $34K | Hold |
121
| – | – | 0.03% | 227 |
|
|
2022
Q1 | $32K | Hold |
121
| – | – | 0.02% | 237 |
|
|
2021
Q4 | $27K | Hold |
121
| – | – | 0.02% | 245 |
|
|
2021
Q3 | $22K | Hold |
121
| – | – | 0.01% | 255 |
|
|
2021
Q2 | $24K | Hold |
121
| – | – | 0.02% | 250 |
|
|
2021
Q1 | $26K | Hold |
121
| – | – | 0.01% | 271 |
|
|
2020
Q4 | $29K | Hold |
121
| – | – | 0.02% | 248 |
|
|
2020
Q3 | $33K | Hold |
121
| – | – | 0.02% | 228 |
|
|
2020
Q2 | $35K | Hold |
121
| – | – | 0.02% | 219 |
|
|
2020
Q1 | $29K | Buy |
+121
| New | +$29K | 0.02% | 228 |
|